News About: Pharm. Industry
GSK’s Avandia to be hit by near-blanket ban
The Korea Food and Drug Administration will deal a powerful blow to GlaxoSmithKline by issuing a near-blanket ban on sales of Avandia, the UK pharmaceutical group’s top-selling diabetes drug, according to market insid...
Development of local biodrugs to be promoted
The Korea Food and Drug Administration said on September 28 it has established a consultative review body to boost the development of new biodrugs.
The project, named “Dynamic BIO,” aims to develop a variety of new...
Drug makers, bioventure firms seek win-win strategy
To seek new growth amid tight competition, more and more local drug makers are teaming up with bioventure firms for joint tech development.
For pharmaceutical companies that lack knowledge and skills, cooperating ...
Boryung to present clinical results of new antihypertensive agent
Boryung Pharmaceutical Co., one of Korea's largest pharmaceutical companies, said it will announce the results of safety and efficacy on a new antihypertensive drug in the 23rd Scientific Meeting of International Soci...
Dong-A, Astellas Korea cooperate over co-promotion of Irribow
Dong-A Pharmaceutical has joined hands with Astellas Pharma Korea to make a joint marketing of Irribow (ramosetron), serotonin 5-HT3 receptor antagonist which is indicated for diarrhea-predominant irritable bowel synd...
Daewha to increase production line for patches
Daewha Pharm announced on September 16 a remodeling plan to increment its production line for medical patches in Haengsung GMP plant of Kangwon Province.
The company said in its regulatory filing that it will inves...
Choong-wae releases SkinFill
Choong-wae Pharm said September 16 it has released SkinFill developed by Italia based Promoitalia Group to strengthen its position in the local cosmetic surgery market.
Among the techniques that are gaining popular...
Government to acknowledge donations by pharmaceutical companies in international scientific conferen
The government will allow pharmaceutical firms to support overseas academic conferences here without restriction.
In a press interview on September 16, the health minister Chin Soo-hee said the ministry is consider...
285 antihypertensive drugs to be excluded from insurance
The Health Insurance Review Assessment and Service announced on September 13 that health insurance will no longer cover a total of 285 antihypertensive agents which have been on market since 2006.
The agency said t...
Individual investor buys 6.4% stake in Samil Pham
An individual investor, known as Choi, bought 350,000 shares of Samil Pharm this month, increasing his stake to 6.4 percent of the total on September 14.
Samil shares closed at 5,500 won on the day, meaning Choi’s ...
